# Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App

> **NCT04675645** · NA · COMPLETED · sponsor: **Ann & Robert H Lurie Children's Hospital of Chicago** · enrollment: 33 (actual)

## Conditions studied

- Sickle Cell Disease
- Sickle B+ Thalassemia
- Sickle Beta Zero Thalassemia
- Sickle Cell Hemoglobin C

## Interventions

- **OTHER:** HU-Go app

## Key facts

- **NCT ID:** NCT04675645
- **Lead sponsor:** Ann & Robert H Lurie Children's Hospital of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-15
- **Primary completion:** 2020-07-11
- **Final completion:** 2020-07-11
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2021-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04675645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04675645, "Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04675645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*